Jean-Francois A Md Dhainaut


Ontology type: schema:Person     


Person Info

NAME

Jean-Francois A Md

SURNAME

Dhainaut

Publications in SciGraph latest 50 shown

  • 2011-06-21 Unblinding plan of PROWESS-SHOCK trial in INTENSIVE CARE MEDICINE
  • 2010-11-25 Erratum to: Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock in INTENSIVE CARE MEDICINE
  • 2010-08-06 Statistical analysis plan of PROWESS SHOCK study in INTENSIVE CARE MEDICINE
  • 2009-05-14 Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock in INTENSIVE CARE MEDICINE
  • 2009-05-07 Can metabolic abnormalities after a fall predict short term mortality in elderly patients? in EUROPEAN JOURNAL OF EPIDEMIOLOGY
  • 2009-03-18 Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis in CRITICAL CARE
  • 2009-03-05 Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock in INTENSIVE CARE MEDICINE
  • 2009-01-09 The PROWESS SHOCK trial: reply to Paramesh et al. in INTENSIVE CARE MEDICINE
  • 2008-11-07 Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock in INTENSIVE CARE MEDICINE
  • 2008-10-07 Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock in INTENSIVE CARE MEDICINE
  • 2008-09-11 Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis in CRITICAL CARE
  • 2008-03-13 Extended drotrecogin alfa (activated) therapy in patients with persistent requirement for vasopressor support after 96-hour infusion with commercial drotrecogin alfa (activated) in CRITICAL CARE
  • 2008-02-29 Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 in INTENSIVE CARE MEDICINE
  • 2008-02-08 Is myocardial adrenergic responsiveness depressed in human septic shock? in INTENSIVE CARE MEDICINE
  • 2007-12-19 Diagnosis and treatment of severe sepsis in CRITICAL CARE
  • 2007-12-04 Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 in INTENSIVE CARE MEDICINE
  • 2007-09-06 Cost-effectiveness of activated protein C in real-life clinical practice in CRITICAL CARE
  • 2006-11-10 How emergency departments might alert for prehospital heat-related excess mortality? in CRITICAL CARE
  • 2006-09-11 Risk factors for post-ICU red blood cell transfusion: a prospective study in CRITICAL CARE
  • 2006-06-15 Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome in CRITICAL CARE
  • 2006-03-21 Noninvasive monitoring of cardiac output in critically ill patients: transesophageal Doppler vs transesophageal echocardiography in CRITICAL CARE
  • 2005-08-25 Re-establishing organ function in severe sepsis: targeting the microcirculation in CRITICAL CARE
  • 2004-03-30 A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker in INTENSIVE CARE MEDICINE
  • 2004-03-15 The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS in CRITICAL CARE
  • 2004-03-15 The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS in CRITICAL CARE
  • 2004-03-15 Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS in CRITICAL CARE
  • 2004-03-15 Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis patients with two or more organ dysfunctions at baseline: results from ENHANCE in CRITICAL CARE
  • 2004-02-10 Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] in CRITICAL CARE
  • 2003-12-04 Unprecedented heat-related deaths during the 2003 heat wave in Paris: consequences on emergency departments in CRITICAL CARE
  • 2003-05-08 The PIRO Concept: R is for response in CRITICAL CARE
  • 2003-04-24 Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial in INTENSIVE CARE MEDICINE
  • 2002-10 Pharmacokinetic‐pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2002 Coronary Circulation in Sepsis in CORONARY CIRCULATION AND MYOCARDIAL ISCHEMIA
  • 2001-10 A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome in INTENSIVE CARE MEDICINE
  • 2001-05 Myocardial Dysfunction in Sepsis in SEPSIS
  • 2001 Perspectives in Anti-Inflammatory Therapies in Sepsis in EVOLVING CONCEPTS IN SEPSIS AND SEPTIC SHOCK
  • 2000-07 Association of PEEP with two different inflation volumes in ARDS patients: effects on passive lung deflation and alveolar recruitment in INTENSIVE CARE MEDICINE
  • 2000-03-21 Meeting the needs of ICU patient families: a multicentre study in CRITICAL CARE
  • 2000-03-21 Anxiety and depression in family members of ICU patients: ethical considerations regarding decision-making capacity in CRITICAL CARE
  • 1998-10 Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study in INTENSIVE CARE MEDICINE
  • 1998 Right Ventricular Function in ALI and ARDS in ACUTE LUNG INJURY
  • 1997-11 The use, and misuse, of exogenous endothelial-derived vasodilators in acute respiratory failure in INTENSIVE CARE MEDICINE
  • 1997 Human Polymorphonuclear Leucocyte Metabolism and Lipoperoxidation During Adult Respiratory Distress Syndrome in ADVANCES IN CRITICAL CARE TESTING
  • 1996-09 Reproducibility of thermodilution cardiac output determination in critically ill patients: Comparison between bolus and continuous method in JOURNAL OF CLINICAL MONITORING
  • 1995 Investigational Therapy of Sepsis: Anti-TNF, IL-1ra, Anti-PAF and G-CSF in CLINICAL TRIALS FOR THE TREATMENT OF SEPSIS
  • 1995-01 Reduction of ventilator settings allowed by intravenous oxygenator (IVOX) in ARDS patients in INTENSIVE CARE MEDICINE
  • 1995 Hepatic Acute-Phase Response in THE SPLANCHNIC CIRCULATION
  • 1995 Inhaled Nitric Oxide: The Light and Shadow of a Therapeutic Breakthrough in ROLE OF NITRIC OXIDE IN SEPSIS AND ADRS
  • 1995 Mechanical Ventilation should be Individually Optimized in Patients with ARDS in YEARBOOK OF INTENSIVE CARE AND EMERGENCY MEDICINE
  • 1994-08 Lack of efficacy of inhaled nitric oxide in ARDS in INTENSIVE CARE MEDICINE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.413328.f", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411147.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417540.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410463.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7942.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240223.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416356.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411784.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411374.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.152326.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411896.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7429.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414474.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.508487.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10388.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414106.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8515.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412687.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413629.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411394.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413482.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.48769.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.462098.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267308.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7010.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412116.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411119.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412157.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.40263.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.498924.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5012.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.457361.2", 
            "type": "Organization"
          }
        ], 
        "familyName": "Dhainaut", 
        "givenName": "Jean-Francois A Md", 
        "id": "sg:person.0737311472.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737311472.48"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-05-20T08:04", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/person/person_713.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0737311472.48'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0737311472.48'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0737311472.48'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0737311472.48'


     

    This table displays all metadata directly associated to this object as RDF triples.

    78 TRIPLES      10 PREDICATES      42 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0737311472.48 schema:affiliation Naacb20df5ada476e904af12eb2efddee
    2 grid-institutes:grid.10388.32
    3 grid-institutes:grid.152326.1
    4 grid-institutes:grid.240223.5
    5 grid-institutes:grid.267308.8
    6 grid-institutes:grid.40263.33
    7 grid-institutes:grid.410463.4
    8 grid-institutes:grid.411119.d
    9 grid-institutes:grid.411147.6
    10 grid-institutes:grid.411374.4
    11 grid-institutes:grid.411394.a
    12 grid-institutes:grid.411784.f
    13 grid-institutes:grid.411896.3
    14 grid-institutes:grid.412116.1
    15 grid-institutes:grid.412157.4
    16 grid-institutes:grid.412687.e
    17 grid-institutes:grid.413482.8
    18 grid-institutes:grid.413629.b
    19 grid-institutes:grid.414106.6
    20 grid-institutes:grid.414474.6
    21 grid-institutes:grid.416356.3
    22 grid-institutes:grid.417540.3
    23 grid-institutes:grid.457361.2
    24 grid-institutes:grid.462098.1
    25 grid-institutes:grid.48769.34
    26 grid-institutes:grid.498924.a
    27 grid-institutes:grid.5012.6
    28 grid-institutes:grid.508487.6
    29 grid-institutes:grid.7010.6
    30 grid-institutes:grid.7429.8
    31 grid-institutes:grid.7942.8
    32 grid-institutes:grid.8515.9
    33 schema:familyName Dhainaut
    34 schema:givenName Jean-Francois A Md
    35 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737311472.48
    36 schema:sdDatePublished 2022-05-20T08:04
    37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    38 schema:sdPublisher N28565024f3a14b4fb0bcc0ed17bb0196
    39 sgo:license sg:explorer/license/
    40 sgo:sdDataset persons
    41 rdf:type schema:Person
    42 N28565024f3a14b4fb0bcc0ed17bb0196 schema:name Springer Nature - SN SciGraph project
    43 rdf:type schema:Organization
    44 Naacb20df5ada476e904af12eb2efddee schema:affiliation grid-institutes:grid.413328.f
    45 sgo:isCurrent true
    46 rdf:type schema:OrganizationRole
    47 grid-institutes:grid.10388.32 schema:Organization
    48 grid-institutes:grid.152326.1 schema:Organization
    49 grid-institutes:grid.240223.5 schema:Organization
    50 grid-institutes:grid.267308.8 schema:Organization
    51 grid-institutes:grid.40263.33 schema:Organization
    52 grid-institutes:grid.410463.4 schema:Organization
    53 grid-institutes:grid.411119.d schema:Organization
    54 grid-institutes:grid.411147.6 schema:Organization
    55 grid-institutes:grid.411374.4 schema:Organization
    56 grid-institutes:grid.411394.a schema:Organization
    57 grid-institutes:grid.411784.f schema:Organization
    58 grid-institutes:grid.411896.3 schema:Organization
    59 grid-institutes:grid.412116.1 schema:Organization
    60 grid-institutes:grid.412157.4 schema:Organization
    61 grid-institutes:grid.412687.e schema:Organization
    62 grid-institutes:grid.413328.f schema:Organization
    63 grid-institutes:grid.413482.8 schema:Organization
    64 grid-institutes:grid.413629.b schema:Organization
    65 grid-institutes:grid.414106.6 schema:Organization
    66 grid-institutes:grid.414474.6 schema:Organization
    67 grid-institutes:grid.416356.3 schema:Organization
    68 grid-institutes:grid.417540.3 schema:Organization
    69 grid-institutes:grid.457361.2 schema:Organization
    70 grid-institutes:grid.462098.1 schema:Organization
    71 grid-institutes:grid.48769.34 schema:Organization
    72 grid-institutes:grid.498924.a schema:Organization
    73 grid-institutes:grid.5012.6 schema:Organization
    74 grid-institutes:grid.508487.6 schema:Organization
    75 grid-institutes:grid.7010.6 schema:Organization
    76 grid-institutes:grid.7429.8 schema:Organization
    77 grid-institutes:grid.7942.8 schema:Organization
    78 grid-institutes:grid.8515.9 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...